Special Issue "COVID-19 and Global Chronic Disease"
Deadline for manuscript submissions: 15 December 2021.
Interests: antiaging research; anti-aging genes; appetite; environment; nutrition; senescence
Special Issues and Collections in MDPI journals
Special Issue in Proteomes: Proteomics-Based Development of Biomarkers in Global Chronic Disease
Special Issue in Vaccines: Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World
The World Health Organization was informed by Chinese authorities of an outbreak of a novel strain of coronavirus called SARS-CoV-2. As of February 20, 2020, nearly 167,500 COVID-19 cases had been documented and the virus had killed over 6,600 people. The infected individuals may experience mild illness and recover while others can become seriously ill and die. Chronic diseases such as obesity, diabetes, and neurodegenerative diseases are expected to increase in the next 30 years and non-alcoholic fatty liver disease (NAFLD) to reach between 30-40% of the global population. These chronic diseases are associated with an altered immune system that leads to severe illnesses after virus infections. In the developing world, the major concern with COVID-19 infection is that it may lead to multiple organ disease syndrome and the severity of COVID-19 in these individuals may be associated with gene inactivation and linked to programmed cell death. The role of diet, nutrition, and appetite control may be critical to stabilize the immune system and reverse the severity of the disease connected to the global chronic disease epidemic.
This Special Issue, titled “COVID-19 and Global Chronic Disease,” will aim to assess the increased concerns for COVID-19 infections in individuals within the global chronic disease epidemic. Diet and lifestyles are important to reduce COVID-19 infection and severity that may be linked to a defective immune system. We have published several articles related to the global chronic disease epidemic in 2018 and 2019 which have successfully obtained many citations. In 2021, we would like to publish various articles as indicated in the keywords below.
Dr. Ian James Martins
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Gene inactivation
- Chronic disease
- Immune system